Docoh
Loading...

ZNTL Zentalis Pharmaceuticals

News

From Benzinga Pro
10 Biggest Price Target Changes For Friday
17 Dec 21
Price Target, Pre-Market Outlook, Analyst Ratings
Piper Sandler boosted Accenture plc (NYSE: ACN) price target from $354 to $433. Accenture shares dropped 0.4% to $399.00 in pre-market trading.
SVB Leerink Maintains Outperform on Zentalis Pharmaceuticals, Raises Price Target to $97
17 Dec 21
News, Price Target, Analyst Ratings
SVB Leerink analyst Andrew Berens maintains Zentalis Pharmaceuticals (NASDAQ:ZNTL) with a Outperform and raises the price target from $89 to $97.
SVB Leerink Maintains Outperform on Zentalis Pharmaceuticals, Raises Price Target to $89
10 Dec 21
News, Price Target, Analyst Ratings
SVB Leerink analyst Andrew Berens maintains Zentalis Pharmaceuticals (NASDAQ:ZNTL) with a Outperform and raises the price target from $84 to $89.
HC Wainwright & Co. Maintains Buy on Zentalis Pharmaceuticals, Raises Price Target to $120
11 Nov 21
News, Price Target, Analyst Ratings
HC Wainwright & Co. analyst Andrew Fein maintains Zentalis Pharmaceuticals (NASDAQ:ZNTL) with a Buy and raises the price target from $80 to $120.
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
10 Nov 21
Biotech, Earnings, News, Penny Stocks, Guidance, Offerings, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours.
Zentalis Pharmaceuticals Q3 EPS $(0.09) Up From $(0.91) YoY
10 Nov 21
Earnings, News
Zentalis Pharmaceuticals (NASDAQ:ZNTL) reported quarterly losses of $(0.09) per share. This is a 90.11 percent increase over losses of $(0.91) per share from the same period last year.
Notable Zentalis Pharmaceuticals Insider Trades $3.4M In Company Stock
28 Oct 21
News, Insider Trades, Trading Ideas
Alexis Pinto, Chief Legal Officer at Zentalis Pharmaceuticals (NASDAQ:ZNTL), made a large buy and sell of company shares on October 25, according to a new SEC filing.